Sunday, October 07, 2007

Lamisil Approved to Treat Ringworm of the Scalp

(HealthDay News) -- The U.S. Food and Drug Administration has approved a new oral form of the Novartis drug Lamisil (terbinafine hydrochloride) to treat people age 4 years and older with tinea capitis, a contagious infection commonly called ringworm of the scalp.

Most of the 3 million to 4 million people in the United States with the condition are children under age 10, Novartis said in announcing the approval. The newly approved Lamisil Oral Granules are meant to be taken once daily for six weeks.

People with liver or kidney problems, and pregnant and nursing women, shouldn't take the drug unless directed by a physician, Novartis said. In addition, the company said Lamisil could interact with other medications, including some popular antidepressants, beta-blockers, and antiarrhythmics.

Lamisil Oral Granules are expected on U.S. pharmacy shelves starting in January 2008, Novartis said.

More information
Here's more about this approval from the FDA.

No comments:

Dr. Group's Secret to Health Kit

Dr. Group's Secret to Health Kit

$39.94
[ learn more ]

Add to Cart

Dr. Group's Secret to Health Kit offers simple at-home solutions for cleansing internally and externally thereby reducing toxins, restoring the body's natural healing process, and helping you achieve true health and happiness.

Advanced Body Cleansing Kit

Advanced Body Cleansing Kit

$147.75
[ learn more ]

Add to Cart

Advanced Body Cleansing Kit with Livatrex™, Oxy-Powder®, Latero-Flora™ and two bottles of ParaTrex®.